Picture of Nightingale Health Oyj logo

HEALTH — Nightingale Health Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Nightingale Health July 2020-June 2021 EBITDA Loss Widens To EUR 4.75 Million

Sept 15 (Reuters) - Nightingale Health Oyj  HEALTH.HE :
    * JULY 2020-JUNE 2021 REVENUE WAS EUR 2.08 (1.78) MILLION
    * JULY 2020-JUNE 2021 EBITDA WAS EUR -4.75 (-3.11) MILLION
    * PROPOSES TO ANNUAL GENERAL MEETING THAT NO DIVIDEND WILL
BE
DISTRIBUTED FOR FINANCIAL YEAR 1 JULY 2020 - 30 JUNE 2021
    * TARGETS FOR FINANCIAL YEAR 2021-2022: REACHING AN ORDER
BOOK OF
EUR 5 MILLION BY END OF FINANCIAL YEAR
    * TARGETS FOR FINANCIAL YEAR 2021-2022:  SIGNING AN
INTERNATIONAL
COMMERCIAL PARTNERSHIP AGREEMENT

Source text for Eikon:  ID:nWkr8qwFww 
Further company coverage:  HEALTH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nightingale Health Oyj

See all news